Nitrogen ( DrugBank: Nitrogen )


2 diseases
IDDisease name (Link within this page)Number of trials
6Parkinson disease1
299Cystic fibrosis2

6. Parkinson disease


Clinical trials : 2,298 Drugs : 2,202 - (DrugBank : 350) / Drug target genes : 188 - Drug target pathways : 202
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1JPRN-UMIN000010014
2013/02/2813/02/2013Randomized Double-blind, Placebo-controlled multi-center trial on molecular hydrogen water in Parkinson Disease Parkinson's disesasehydrogen water made by "Suisosui5.0"
placebo-water (nitrogen filling water)
Juntendo University School of Medicine, NeurologyNULLComplete: follow-up complete20years-oldNot applicableMale and Female200Not selectedJapan

299. Cystic fibrosis


Clinical trials : 1,696 Drugs : 1,644 - (DrugBank : 272) / Drug target genes : 96 - Drug target pathways : 170
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT02950116
(ClinicalTrials.gov)
March 9, 201711/10/2016Lung Clearance Index (LCI) in Pediatric Patients With Obstructive Lung DiseaseLung Clearance Index in Pediatric Patients With Obstructive Lung DiseaseAsthma;Bronchiectasis;Cystic FibrosisDevice: Perform three multiple breath nitrogen washout tests (N2-MBW-test)Universitair Ziekenhuis BrusselNULLTerminated6 Years17 YearsAll27N/ABelgium
2NCT00570349
(ClinicalTrials.gov)
July 20046/12/2007Safety and Tolerability of Inhaled Nitric Oxide in Patients With Cystic FibrosisSafety and Tolerability of Inhaled Nitric Oxide in Patients With Cystic FibrosisCystic FibrosisDrug: Nitric Oxide for Inhalation;Drug: NitrogenMallinckrodtNULLCompleted12 YearsN/AAll18Phase 1/Phase 2United States